Lisanti Capital Growth’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-19,460
| Closed | -$3.19M | – | 143 |
|
|
2025
Q4 | $3.19M | Buy |
+19,460
| New | +$3.05M | 0.76% | 64 |
|
|
2024
Q2 | – | Sell |
-3,870
| Closed | -$712K | – | 135 |
|
|
2024
Q1 | $712K | Buy |
3,870
+1,445
| +60% | +$275K | 0.17% | 113 |
|
|
2023
Q4 | $436K | Sell |
2,425
-11,715
| -83% | -$1.82M | 0.1% | 123 |
|
|
2023
Q3 | $2.25M | Buy |
+14,140
| New | +$2.31M | 0.36% | 95 |
|
|
2022
Q4 | – | Sell |
-20,415
| Closed | -$3.82M | – | 155 |
|
|
2022
Q3 | $3.82M | Buy |
20,415
+7,225
| +55% | +$1.52M | 0.51% | 82 |
|
|
2022
Q2 | $2.14M | Buy |
+13,190
| New | +$2.09M | 0.29% | 91 |
|
|
2022
Q1 | – | Sell |
-16,430
| Closed | -$4.35M | – | 141 |
|
|
2021
Q4 | $4.35M | Sell |
16,430
-570
| -3% | -$154K | 0.63% | 67 |
|
|
2021
Q3 | $4.91M | Buy |
17,000
+11,785
| +226% | +$3.02M | 0.72% | 55 |
|
|
2021
Q2 | $1.04M | Sell |
5,215
-7,495
| -59% | -$1.45M | 0.13% | 130 |
|
|
2021
Q1 | $2.47M | Sell |
12,710
-25,551
| -67% | -$5.24M | 0.32% | 107 |
|
|
2020
Q4 | $7.33M | Buy |
38,261
+280
| +0.7% | +$50.9K | 1.01% | 41 |
|
|
2020
Q3 | $5.6M | Buy |
37,981
+3,500
| +10% | +$500K | 1.04% | 51 |
|
|
2020
Q2 | $4.26M | Sell |
34,481
-51,559
| -60% | -$6.07M | 0.87% | 55 |
|
|
2020
Q1 | $8.31M | Buy |
86,040
+24,093
| +39% | +$2.33M | 2.74% | 2 |
|
|
2019
Q4 | $5.73M | Buy |
61,947
+31,052
| +101% | +$2.61M | 1.52% | 22 |
|
|
2019
Q3 | $2.37M | Sell |
30,895
-58,145
| -65% | -$5.09M | 0.77% | 50 |
|
|
2019
Q2 | $7.65M | Buy |
89,040
+31,905
| +56% | +$2.17M | 2.49% | 3 |
|
|
2019
Q1 | $3.38M | Sell |
57,135
-3,285
| -5% | -$189K | 1.2% | 28 |
|
|
2018
Q4 | $3.19M | Buy |
60,420
+16,015
| +36% | +$939K | 1.29% | 32 |
|
|
2018
Q3 | $2.46M | Buy |
44,405
+15,880
| +56% | +$818K | 0.86% | 54 |
|
|
2018
Q2 | $1.34M | Buy |
+28,525
| New | +$1.17M | 0.51% | 80 |
|
|
2017
Q4 | – | Sell |
-18,435
| Closed | -$706K | – | 126 |
|
|
2017
Q3 | $706K | Sell |
18,435
-31,015
| -63% | -$1.3M | 0.44% | 85 |
|
|
2017
Q2 | $2.05M | Buy |
+49,450
| New | +$1.88M | 1.36% | 22 |
|
|
2017
Q1 | – | Sell |
-26,225
| Closed | -$808K | – | 107 |
|
|
2016
Q4 | $808K | Buy |
26,225
+13,780
| +111% | +$426K | 0.98% | 48 |
|
|
2016
Q3 | $376K | Buy |
+12,445
| New | +$376K | 0.48% | 86 |
|
|
2015
Q4 | – | Sell |
-17,977
| Closed | -$501K | – | 100 |
|
|
2015
Q3 | $501K | Sell |
17,977
-33,073
| -65% | -$1.2M | 0.45% | 83 |
|
|
2015
Q2 | $2.11M | Buy |
+51,050
| New | +$1.87M | 1.52% | 23 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Lisanti Capital Growth's RGEN Position: Q1 2026 in Review
Lisanti Capital Growth sold out of Repligen (RGEN) in Q1 2026, closing a stake of 19,460 shares — an estimated $3.19M sold.
Lisanti Capital Growth first reported a position in RGEN in Q2 2015 and held it in 27 quarters. The position peaked at $8.31M in Q1 2020. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Lisanti Capital Growth reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Lisanti Capital Growth sold 19,460 Repligen shares in Q1 2026, an estimated $3.19M.
- Lisanti Capital Growth first reported a position in Repligen in Q2 2015 and held it in 27 quarters.
- Lisanti Capital Growth's Repligen position peaked at $8.31M in Q1 2020.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Lisanti Capital Growth's 13F filing for Q1 2026, filed 7 May 2026.